These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7941331

  • 1. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R, Tong X, Grossman S, Johannsen E, Mosialos G, Kieff E.
    Virology; 1994 Nov 01; 204(2):634-41. PubMed ID: 7941331
    [Abstract] [Full Text] [Related]

  • 2. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR.
    J Cell Physiol; 1993 Mar 01; 154(3):486-95. PubMed ID: 8382208
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Le Roux A, Kerdiles B, Walls D, Dedieu JF, Perricaudet M.
    Virology; 1994 Dec 01; 205(2):596-602. PubMed ID: 7975264
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T, Sjöblom A, Masucci MG, Rymo L.
    Virology; 1993 Apr 01; 193(2):774-85. PubMed ID: 8384755
    [Abstract] [Full Text] [Related]

  • 8. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD, Hsieh JJ, Ruf IK, Rawlins DR, Hayward SD.
    J Virol; 1994 Sep 01; 68(9):5375-83. PubMed ID: 8057421
    [Abstract] [Full Text] [Related]

  • 9. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S, Watakabe I, Krainer AR, Hearing J.
    Virology; 2000 Sep 15; 275(1):145-57. PubMed ID: 11017796
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
    Ling PD, Ryon JJ, Hayward SD.
    J Virol; 1993 Jun 15; 67(6):2990-3003. PubMed ID: 8388484
    [Abstract] [Full Text] [Related]

  • 12. Antisense to Epstein Barr Virus-encoded LMP1 does not affect the transcription of viral and cellular proliferation-related genes, but induces phenotypic effects on EBV-transformed B lymphocytes.
    Masciarelli S, Mattioli B, Galletti R, Samoggia P, Chichiarelli S, Mearini G, Mattia E.
    Oncogene; 2002 Jun 13; 21(26):4166-70. PubMed ID: 12037673
    [Abstract] [Full Text] [Related]

  • 13. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter.
    Swaminathan S.
    Virology; 1996 Mar 15; 217(2):532-41. PubMed ID: 8610445
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein.
    Chen MR, Zong J, Hayward SD.
    Virology; 1994 Dec 15; 205(2):486-95. PubMed ID: 7975250
    [Abstract] [Full Text] [Related]

  • 16. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
    Wang Y, Finan JE, Middeldorp JM, Hayward SD.
    Virology; 1997 Sep 15; 236(1):18-29. PubMed ID: 9299613
    [Abstract] [Full Text] [Related]

  • 17. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S, Yalamanchili R, Kieff E.
    J Virol; 1998 Dec 15; 72(12):9948-54. PubMed ID: 9811732
    [Abstract] [Full Text] [Related]

  • 18. Biochemistry of latent Epstein-Barr virus infection and associated cell growth transformation.
    Kieff E, Hennessy K, Fennewald S, Matsuo T, Dambaugh T, Heller M, Hummel M.
    IARC Sci Publ; 1985 Dec 15; (60):323-39. PubMed ID: 2998995
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR.
    J Virol; 1995 Jan 15; 69(1):253-62. PubMed ID: 7983717
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.